Patents/Assignees

Incyte Corporation

151 patents in portfolio

US12427154utility2025
Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and Processes Related to Preparing the Same
0 cites
US12428426utility2025
Process and Intermediates for Preparing a JAK1 Inhibitor
0 cites
US12421197utility2025
Aminopyrazine Derivatives as Pi3k-γ Inhibitors
0 cites
US12415809utility2025
Pyrrolotriazine Compounds as Tam Inhibitors
0 cites
US12404272utility2025
Process for Making a PD-1/PD-L1 Inhibitor and Salts and Crystalline Forms Thereof
0 cites
US12396993utility2025
Ruxolitinib Formulation for Reduction of Itch in Atopic Dermatitis
0 cites
US12383541utility2025
ALK2 Inhibitors for the Treatment of Anemia
0 cites
US12384778utility2025
Pyrazolopyridine Compounds and Uses Thereof
0 cites
US12378243utility2025
Quinoline Compounds as Inhibitors of KRAS
0 cites
US12365668utility2025
Aminopyrazine Diol Compounds as Pi3k-y Inhibitors
0 cites
US12358983utility2025
Combination of Anti CD19 Antibody with a BCL-2 Inhibitor and Uses Thereof
0 cites
US12360120utility2025
Biomarkers for Graft-versus-host Disease
0 cites
US12336998utility2025
JAK1 Pathway Inhibitors for the Treatment of Cytokine-related Disorders
0 cites
US12331063utility2025
Hetero-bicyclic Inhibitors of KRAS
0 cites
US12318389utility2025
Formulations of an AXL/MER Inhibitor
0 cites
US12312331utility2025
Imidazolyl Pyrimidinylamine Compounds as CDK2 Inhibitors
0 cites
US12280054utility2025
Treatment of Hidradenitis Suppurativa Using JAK Inhibitors
0 cites
US12268667utility2025
JAK1 Pathway Inhibitors for the Treatment of Prurigo Nodularis
0 cites
US12247026utility2025
Heterocyclic Compounds as Immunomodulators
0 cites
US12247030utility2025
Process for Preparing Compositions Comprising an Enantiomeric Excess of a Substituted Pyrrolo[2,3-d]pyrimidine
0 cites

← PreviousPage 2 of 8Next →